43167-79-9

Basic information

• Product Name: 2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97%
• Synonyms: 2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97%;2,4-Dianilino-6-(4-morpholinyl)-1,3,5-triazine, 97%;6-morpholin-4-yl-2-N,4-N-diphenyl-1,3,5-triazine-2,4-diamine
• CAS NO: 43167-79-9
• Molecular Formula: C₁₉H₂₀N₆O
• Molecular Weight: 348.4
• Mol File: 43167-79-9.mol
• Article Data: 2

Chemical Properties

• Melting Point: 194-196°C
• Boiling Point: 577.5°C at 760 mmHg
• Flash Point: 303.1°C
• Appearance: /
• Density: 1.317g/cm³
• Vapor Pressure: 2.46E-13mmHg at 25°C
• Refractive Index: 1.689
• CAS DataBase Reference: 2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97%(43167-79-9)
• EPA Substance Registry System: 2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97%(43167-79-9)

Safety Data

• Hazardous Substances Data: 43167-79-9(Hazardous Substances Data)

Usage

General Description

2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97% is a chemical compound that is composed of two anilino groups, one morpholino group, and a triazine ring. It is available in a purity of 97%. 2,4-BIS(ANILINO)-6-(4-MORPHOLINO)-1,3,5-TRIAZINE, 97% has potential applications in various industries including pharmaceuticals, agriculture, and materials science. Its unique molecular structure makes it a valuable building block for the synthesis of advanced materials and pharmaceutical compounds. Its high purity level of 97% ensures its reliability and consistency in research and industrial processes.

InChI:InChI=1/C19H20N6O/c1-3-7-15(8-4-1)20-17-22-18(21-16-9-5-2-6-10-16)24-19(23-17)25-11-13-26-14-12-25/h1-10H,11-14H2,(H2,20,21,22,23,24)

Upstream product

• 110-91-8 morpholine 
• 1973-09-7 6-chloro-N,N'-diphenyl-1,3,5-triazine-2,4-diamine 
• 62-53-3 aniline 

Relevant articles and documents

Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives

A series of triaminotriazine derivatives (compounds 5a-f, 6a-x, and 7a-g) was designed, synthesized, and evaluated for their inhibition activities to colorectal cancer (CRC) cell lines (HCT-116 and HT-29). Most of the synthesized compounds demonstrated moderate anti-proliferatory effects on both HCT-116 and HT-29 cell lines at the concentration of 10 μM. The inhibitory activities against HCT-116 and HT-29 cell lines were discussed to develop the structure-activity relationships of this new series. Compounds 6l and 6o exhibited prominent inhibition activities toward HCT-116, with IC50s of 0.76 and 0.92 μM, respectively. The in vivo antitumor studies and pharmacokinetics of compound 6l showed that it might be a promising new hit for further development of antitumor agents.